Roctavian
BioMarin R&D chief reveals two new pipeline candidates and strategy to sustain innovation
Anika Sharma
BioMarin, the California-based biotech giant, is embarking on a mission to create its most robust pipeline in history, with a ...
BioMarin’s Roctavian: FDA Approves Hemophilia A Gene Therapy with Positive Reception from Physician
SG Tylor
Source – BioMarin BioMarin’s Roctavian, a gene therapy for severe hemophilia A, has received FDA approval after initial rejection in ...